abstract |
In a method embodiment, a method includes introducing a plurality of Ideotypically Modulated Pharmacoeffectors (IMP) (1, la, 1b) into a population of cells. Each IMP (1, la, lb) may 5 include a deection domain (2, 2a, 2b) and an activation domain (3, 3a, 3b) . One or more epitopes is bound by the detection domain (2, 2a, 2b) . The activation domain (3, 3a, 3b) is activated in response to the binding. Applications may include but are not limited to viral infections, other intracellular 10 infections, cancers, vector-borne diseases, autoimmune diseases, cellular diseases, cellular enhancement, and research. |